Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylenediamine SCHEMBL28300589 | 0.81 | ALDH1A1 (0.36) | ALDH1A1 | |
| Propylamine SCHEMBL8950138 | 0.79 | — | — | |
| Propylamine SCHEMBL28251290 | 0.76 | DNM1 (0.38) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Propylamine SCHEMBL1330797 | 0.76 | — | — | |
| Propylamine SCHEMBL448871 | 0.76 | — | — | |
| Propylamine SCHEMBL9181 | 0.76 | — | — | |
| Propylamine SCHEMBL1782620 | 0.74 | — | — | |
| Cyclohexane SCHEMBL29170840 | 0.72 | DNM1 (0.41) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Propylamine SCHEMBL28879731 | 0.72 | — | — | |
| Biphenyl SCHEMBL2069545 | 0.72 | CYP1A2 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104672093-B | A kind of preparation method of bicyclo-propyl methylamine | Chengdu Sainz Pharmaceutical Technology Co., Ltd (CN) | 2016-04-13 | — | — | CN | disclosed |
| CN-104672093-A | Method for preparing dicyclopropane methyl amine | CHENGDU SYNS MEDICAL TECHNOLOGY CO LTD | 2015-06-03 | — | — | CN | disclosed |